Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Embryonic structure
Reexamination Certificate
2006-04-25
2006-04-25
Lilling, Herbert J. (Department: 1651)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Embryonic structure
C424S283100, C424S450000, C424S465000
Reexamination Certificate
active
07033612
ABSTRACT:
There is provided a composition for the prevention and treatment of age-related physical and mental disorders that includes phospholipids that have been extracted from chick embryos aged between about 6 days old and about 14 days old. Also provided is a method for extracting these phospholipids by incubating them for between about 6 days to about 14 days. The chick embryos are then prepared for chemical extraction, and the lipids are extracted from the chick embryos. Further provided is a method for preventing and treating age-related physical and mental disorders, in human subjects in need thereof, by administering a sufficient dosage of a composition including phospholipids extracted from chick embryos incubated for between about 6 days and about 14 days to a human subject.
REFERENCES:
patent: 5484611 (1996-01-01), Noble
patent: 5780615 (1998-07-01), Bucala et al.
patent: 5801200 (1998-09-01), Bucala et al.
patent: 6300377 (2001-10-01), Chopra
patent: 6500843 (2002-12-01), Steiner et al.
patent: 6514973 (2003-02-01), Buchholz et al.
patent: 2004/0234544 (2004-11-01), Jager et al.
patent: 2004/0234587 (2004-11-01), Sampalis
patent: 0 437 334 (1995-08-01), None
R. Franson et al,Solubilization and Characterization of a Neutral- Active, Calcium-Dependant, Phosholipase A2from Rabbit Heart and Isolated Chick Embryo Myocytes, J. Mol. Cell Cardiol. 15: 189-196 (1983).
M. Mehlman et al,Studies on the Distribution of Free Camitine and the Occurrence and Nature of Bound Camitine, Arch. Biochem. Biophys. 98: 146-153 (1962).
F. Granata et al,Phosphocholine and phosphoethanolamine During Chick Embryo Myogenesis: a31P-NMR Study, Biochem. Biophys. Acta 1483: 334-342 (2000).
L. Allen et al,Partial Phenotypic Suppression of a Peroxisome-deficient Animal Cell Mutant Treated with Aminoglycoside G418, J. Biol. Chem. 267: 13191-13199 (1992).
G. Arthur et al,The Distribution and Acyl Composition of Plasmalogens in Guinea Pig Heart, Lipids 20:693-698 (1985).
J. Brook et al,Dietary Soya Lecithin Decreases Plasma Triglyceride Levels and Inhibits Collagen- and ADP-Induced Platelet Aggregation, Biochem. Med. Metab. Biol. 35:31-39 (1986).
I. Carrie et al,Phospholipid Supplementation Reverses Behavioral and Biochemical Alterations Induced by N-3 Polyunsaturated Fatty Acid Deficiency in Mice, J. Lipid Res. 41:473-480 (2000).
X. Chen et al,Potassium Flux through Gramicidin Ion Channels is Augmented in Vesicles Comprised of Plasmenylcholine: Correlations between Gramicidin Conformation and Function in Chemically Distinct Host Bilayer Matrices, Biochemistry 34:7356-7364 (1995).
K. Chepenik et al,On the Presence of Plasmologens in Developing Rat Embryos, Int. J. Biochem. 11:605-607 (1980).
I. Delton-Vandenbroucke et al,Dual Regulation of Glutathione Peroxidase by Docosahexaenoic Acid in Endothelial Cells Depending on Concentration and Vascular Bed Origin, Free Radical Biol. Med. 30:895-904 (2001).
A. Diagne et al,Studies of Ether Phospholipids. II Comparative composition of various tissues from human, rat and guinea pig, Biochim. Biophys Acta 793:221-231 (1984).
J. Duhm et al,Accelerated Maximal Velcoity of the Red Blood Cell Na+/K+Pump in Hyperlipidemia is Related to Increase in 1-palmitoyl,2-arachidonoyl-plasmalogen Phosphatidylethanolamine, Biochim. Biophys. Acta 1149:185-188 (1993).
B. Engelmann et al,Plasmalogen Phospholipids as Potential Protectors against Lipid Peroxidation of Low Density Lipoproteins, Biochem. Biophys. Res. Commun. 204:1235-1242 (1994).
H. Goldfine et al,Phase Behavior of Ether Lipids from Clostridium Butyricum, Biochemistry 20:2908-2916 (1981).
H. Goldfine et al,Lipid Shape as a Determinant of Lipid Composition in Clostridium Butyricum: The Effects of Incorporation of Various Fatty Acids on the Ratios of the Major Ether Lipids, Biochim. Biophys. Acta 904:283-289 (1987).
M. Hack et al,On the Plasmalogenation of Myocardial Choline Glycerophospholipid During Maturation of Various Vertebrates, Comp. Biochem. Physiol. 89B:111-118 (1988).
S. Hazen et al,Activation of a Membrane-Associated Phospholipase A2during Rabbit Myocardial Ischemia Which is Highly Selective for Plasmologen Substrate, J. Biol. Chem. 266:5629-5633 (1991).
S. Hazen et al,Purification and Characterization of Canine Myocardial Cytosolic Phospholipase A2A calcium-independent phospholipase with absolute f1-2 regiospecificity for diradyl glycerophospholipids, J. Biol. Chem. 265:10622-10630 (1990).
N. Khaselev et al,Susceptibility of Plasmenyl Glycerophosphoethanolamine Lipids Containing Arachidonate to Oxidative Degradation, Free Radical Biol. Med. 26:275-284 (1999).
M. Lee et al,Phospholipid Functional Groups Involved in Protein Kinase C Activation, Phorbol Ester Binding and Binding to Mixed Micelles, J. Biol. Chem. 264:14797-14805 (1989).
M. Lee et al,Supplementation of the Phosphatidyl-L-serine Requirement of Protein Kinase C with Nonactivating Phospholipids, Biochemistry 31:5176-5182 (1992).
K. Lohner et al,Phase Behavior of Ethanolamine Plasmalogen, Chem. Phys. Lipids 34:163-170 (1984).
A. Maldjian et al,The Transfer of Docosahexaenoic Acid from the Yolk to the Tissues of the Chick Embryo, Biochim. Biophys. Acta 1258:81-89 (1995).
M. Martinez,Docosahexaenoic Acid Therapy in Docosahexaenoic Acid-Deficient Patients with Disorders of Peroxisomal Biogenesis, Lipids 31:S145-S152 (1996).
M. Martinez et al,Therapeutic Effects of Docosahexaenoic Acid Ethyl Ester in Patient with Generalized Peroxisomal Disorders, Am. J. Clin. Nutr. 71:376S-285S (2000).
N. Maulik et al,Fatty Acid Profiles of Plasmalogen Choline and Ethanolamine Glycerophospholipids in Pig and Rat Hearts, J. Pharmaceut. Biomed. Analysis 14: 49-56 (1995).
Y. Nakagawa et al,Changes in the Composition of Fatty Chains of Diacyl, Alkylacyl and Alkenylacyl Ethanolamine and Choline Phosphoglycerides During the Development of Chick Heart Ventricular Cells, Biochim. Biophys. Acta 712:667-676 (1982).
N. Nagan et al,A Fibroblast Cell Line Defective in Alkyl-Dihydroxyacetone Phosphate Synthase: A Novel Defect in Plasmalogen Biosynthesis, Proc. Natl. Acad. Sci. USA 94:4475-4480 (1997).
D. Neel et al,Changes in Phospholipids from Chick Fibroblasts during Embryo Development, Biochem. Biophys. Res. Commun. 98:21-27 (1981).
A. Rizzo et al,Phospholipid Distribution and Fatty Acid Composition in Different Brain Regions during Chick Embryo Development, J. Neurochem. 64: 1728-1733 (1995).
P. Sindelar et al,The Protective Role of Plasmologens in Iron-Induced Lipid Peroxidation, Free Radical Biol. Med. 26: 318-324 (1999).
T. Sugiura et al,Ether Lysophospholipid-induced Production of Platelet-Activating Factor in Human Polymorphonuclear Leukocytes, Biochim. Biophys. Acta 1047:223-232 (1990).
P. Thome et al,Clofibrate and Other Peroxisomal Proliferating Agents Relatively Specifically Inhibit Synthesis of Ethanolamine Phosphoglycerides in Cultured Human Fibroblasts, Biochim. Biophys. Acta 1214:161-170 (1994).
L. Torello et al,A Comparative-Evolutionary Study of Lipids in the Aging Brain of Mice, Neurobiol. Aging 7:337-346 (1986).
Y. Uemura et al,A Coenxyme A-independent Transacylase Is Linked to the Formation of Platelet-Activating Factor(PAF)by Generating the Lyso-PAF Intermediate in the Remodeling Pathway, J. Biol. Chem. 266:8268-8272 (1991).
M. Venable et al,Conversion of 1-O-[3H]Alkyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine to Lyso Platelet-activating Factor by the CoA-independent Transacylase in Membrane Fractions of Human Neutrophils, J. Biol. Chem. 266:18691-18698 (1991).
J. Wojcicki et al,Effects of “Essential” Phospholipids(EPL)on Experimental Ethanol-Induced Cardiomyopathy, Arzneimit. Forsch. (Drug Rs.) 25:1420-1422 (1975).
R. Zoeller et al,A Possible Role for Plasmalogens in Protecting Animal Cells against Photosensitized Killing, J. Biol. Chem. 263:11590-11596 (1988).
Kang Chunghee Kimberly
Kang David S.
LandOfFree
Composition and method for treating age-related disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for treating age-related disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for treating age-related disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3560150